Integral Health Asset Management’s Insulet PODD Stock Holding History

Integral Health Asset Management’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-20,000	Closed	-$5.22M	–	101
2024 Q4	$5.22M	Buy	+20,000	New	+$5.04M	0.45%	62
2024 Q3	–	Sell	-25,000	Closed	-$5.04M	–	91
2024 Q2	$5.04M	Buy	+25,000	New	+$4.51M	0.48%	51
2022 Q4	–	Sell	-25,000	Closed	-$5.74M	–	85
2022 Q3	$5.74M	Buy	+25,000	New	+$6.26M	1.11%	38
2021 Q2	–	Sell	-10,000	Closed	-$2.61M	–	86
2021 Q1	$2.61M	Buy	+10,000	New	+$2.68M	0.75%	45
2020 Q4	–	Sell	-22,000	Closed	-$5.21M	–	81
2020 Q3	$5.21M	Buy	22,000 +4,000	+22%	+$842K	1.59%	22
2020 Q2	$3.5M	Buy	+18,000	New	+$3.44M	1.05%	40

Other funds holding PODD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Integral Health Asset Management's PODD Position: Q1 2025 in Review

Integral Health Asset Management sold out of Insulet (PODD) in Q1 2025, closing a stake of 20,000 shares — an estimated $5.22M sold.

Integral Health Asset Management first reported a position in PODD in Q2 2020 and held it in 6 quarters. The position peaked at $5.74M in Q3 2022. 719 funds tracked by Wall St. Rank hold PODD as of Q1 2025.

Integral Health Asset Management reported no remaining Insulet position as of Q1 2025 after selling out during the quarter.
Integral Health Asset Management sold 20,000 Insulet shares in Q1 2025, an estimated $5.22M.
Integral Health Asset Management first reported a position in Insulet in Q2 2020 and held it in 6 quarters.
Integral Health Asset Management's Insulet position peaked at $5.74M in Q3 2022.
719 funds tracked by Wall St. Rank held Insulet as of Q1 2025.

Based on Integral Health Asset Management's 13F filing for Q1 2025, filed 15 May 2025.